So (in our opinion) the time has come — for a whole bunch of reasons — for actual and potential prostate cancer patients to start asking their urologists about whether they are able to carry out transperineal as opposed to transrectal biopsies. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: benefit, biopsy, risk, transperineal, transrectal | 12 Comments »
A newly published article by Shoag et al. in the New England Journal of Medicine (NEJM) has suggested that the risks associated with “screening” for prostate cancer using the PSA test may not be as high as previously suggested. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: benefit, PSA, risk, screening, test | 4 Comments »
A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: approval, benefit, devices, FDA, HIFU, information, medical, patient, preference, risk | Leave a comment »
An interesting new article in The ASCO Post tells us almost as much about the physicians who treat prostate cancer as it does about the options that are available to patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, benefit, option, risk, surveillance | 11 Comments »
A newly published article in BJU International has (finally) proven something many prostate cancer educators and advocates have known for years: many patients have a very poor appreciation of the risks and benefits of their differing treatment options at the time they make decisions about first-line treatment for localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: accuracy, benefit, knowledge, patient, risk, Treatment, understanding | 5 Comments »
To quote the abstract of the paper discussed below, the use of the PSA test to screen for risk of prostate cancer “in men at normal risk of prostate cancer is one of the most contested issues in cancer screening.” No! Really? … READ MORE …
Filed under: Diagnosis, Risk | Tagged: benefit, diagosis, PSA, risk, screening, testing | 3 Comments »
Kaiser Permanente maintains a large data registry in order to assess the quality of outcomes over time among tens of thousands of Kaiser patients, prostate cancer patients included. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: benefit, life, quality, risk, Treatment | 6 Comments »
A new update on the prostate cancer outcomes of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial has given us a rather different interpretation of the meaning of the data from this trial — although whether that “meaning” actually has “meaning” is probably up for debate. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: benefit, mortality, risk, screening, testing | 7 Comments »
A newly published article in the journal Science Translational Medicine has questioned the merits of treating prostate cancer patients with immunotherapies while they are simultaneously being treated with medical forms of castration (androgen deprivation therapy or ADT), chemotherapy, and/or radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, benefit, chenotherapy, combination, immunotherapy, radiation, risk, timing | 6 Comments »
Four very recent articles and presentations have addressed issues relevant to the use of the PSA test in testing/screening for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: benefit, Diagnosis, PSA, risk, screening, testing | 9 Comments »
Testosterone levels tend to fall in most men as we age. This is hardly new information! An article this week in the New England Journal of Medicine suggests that treatment with testosterone gels is appropriate for aging men with low testosterone levels (hypogonadism). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: benefit, hypogonadism, outcome, risk, supplement, testosterone | 6 Comments »
Yesterday the U.S. Preventive Services Task Force (USPSTF) posted detailed information about a new draft research plan related to screening for prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: benefit, PSA, research, risk, screening, testing, USPSTF | 6 Comments »
Yesterday the American Society of Clinical Oncology (ASCO) issued the initial draft of “a conceptual framework for assessing the value of new cancer therapies based on treatment benefits, toxicities, and costs.” ASCO is interested in getting feedback from its members and from the patient community too. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: benefit, cost, drug, Treatment, value | 5 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 